University of Texas Southwestern Medical Center USA
14 years of basic science research, translational science research, and clinical care in academia as a faculty at Johns Hopkins University, University of Chicago, and UTSouthwestern as a board-certified gastroenterologist specializing in the treatment of patients with inflammatory bowel disease (IBD). Previous Director of the clinical IBD program and the Clinical and Translational IBD Research Core at UT Southwestern Medical Center. Joined Eli Lilly and Company in 2019 as a Senior Medical Advisor in early immunology and clinical trials.